Steve Valiquette
Stock Analyst at Barclays
(1.47)
# 3,485
Out of 5,053 analysts
158
Total ratings
45.87%
Success rate
-3.54%
Average return
Main Sectors:
Stocks Rated by Steve Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BKD Brookdale Senior Living | Maintains: Equal-Weight | $7.5 → $8 | $10.10 | -20.79% | 5 | Aug 7, 2025 | |
| TDOC Teladoc Health | Maintains: Overweight | $10 → $12 | $7.55 | +58.94% | 13 | Oct 31, 2024 | |
| MCK McKesson | Maintains: Overweight | $596 → $616 | $856.58 | -28.09% | 6 | Aug 8, 2024 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $9 | $3.05 | +195.57% | 7 | Mar 1, 2024 | |
| HOUS Anywhere Real Estate | Maintains: Underweight | $4.5 → $5 | $11.84 | -57.77% | 3 | Feb 20, 2024 | |
| MPW Medical Properties Trust | Maintains: Overweight | $12 → $10 | $5.01 | +99.60% | 5 | Aug 22, 2023 | |
| HR Healthcare Realty Trust | Maintains: Equal-Weight | $25 → $24 | $18.07 | +32.85% | 4 | Aug 11, 2023 | |
| CVS CVS Health | Maintains: Overweight | $89 → $86 | $77.83 | +10.50% | 14 | Aug 3, 2023 | |
| CNC Centene | Maintains: Overweight | $86 → $85 | $34.87 | +143.76% | 6 | Jul 31, 2023 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $275 → $300 | $458.94 | -34.63% | 4 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $35 → $34 | $36.25 | -6.21% | 3 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $105 | $197.23 | -46.76% | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $55 | $76.28 | -27.90% | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $13 | $19.04 | -31.70% | 11 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $132 → $142 | $223.20 | -36.38% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $5 | $32.69 | -84.70% | 4 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $57 | $114.90 | -50.39% | 2 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $82 | $190.74 | -57.01% | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $17.77 | +1.32% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $31 | $43.98 | -29.51% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $375 | $142.60 | +162.97% | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $37.00 | -48.65% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $570 | $243.25 | +134.33% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $70 → $64 | $204.88 | -68.76% | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $275 → $310 | $258.21 | +20.06% | 16 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $495 → $565 | $320.80 | +76.12% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $150 → $75 | $3.42 | +2,092.98% | 4 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $26 → $19 | $4.82 | +294.60% | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $10 | $3.60 | +178.16% | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $42 → $34 | $28.17 | +20.72% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $8.96 | +123.21% | 1 | May 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $260 | $87.44 | +197.36% | 1 | Feb 19, 2021 |
Brookdale Senior Living
Aug 7, 2025
Maintains: Equal-Weight
Price Target: $7.5 → $8
Current: $10.10
Upside: -20.79%
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10 → $12
Current: $7.55
Upside: +58.94%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596 → $616
Current: $856.58
Upside: -28.09%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8 → $9
Current: $3.05
Upside: +195.57%
Anywhere Real Estate
Feb 20, 2024
Maintains: Underweight
Price Target: $4.5 → $5
Current: $11.84
Upside: -57.77%
Medical Properties Trust
Aug 22, 2023
Maintains: Overweight
Price Target: $12 → $10
Current: $5.01
Upside: +99.60%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $18.07
Upside: +32.85%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89 → $86
Current: $77.83
Upside: +10.50%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86 → $85
Current: $34.87
Upside: +143.76%
HCA Healthcare
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275 → $300
Current: $458.94
Upside: -34.63%
May 3, 2023
Maintains: Underweight
Price Target: $35 → $34
Current: $36.25
Upside: -6.21%
Apr 26, 2023
Maintains: Overweight
Price Target: $70 → $105
Current: $197.23
Upside: -46.76%
Apr 25, 2023
Maintains: Overweight
Price Target: $57 → $55
Current: $76.28
Upside: -27.90%
Apr 25, 2023
Maintains: Equal-Weight
Price Target: $15 → $13
Current: $19.04
Upside: -31.70%
Apr 25, 2023
Upgrades: Equal-Weight
Price Target: $132 → $142
Current: $223.20
Upside: -36.38%
Apr 5, 2023
Maintains: Underweight
Price Target: $13 → $5
Current: $32.69
Upside: -84.70%
Mar 14, 2023
Initiates: Equal-Weight
Price Target: $57
Current: $114.90
Upside: -50.39%
Jan 17, 2023
Maintains: Overweight
Price Target: $78 → $82
Current: $190.74
Upside: -57.01%
Jan 17, 2023
Maintains: Overweight
Price Target: $20 → $18
Current: $17.77
Upside: +1.32%
Jan 17, 2023
Maintains: Equal-Weight
Price Target: $33 → $31
Current: $43.98
Upside: -29.51%
Jan 4, 2023
Maintains: Overweight
Price Target: $400 → $375
Current: $142.60
Upside: +162.97%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $37.00
Upside: -48.65%
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $570
Current: $243.25
Upside: +134.33%
May 26, 2022
Downgrades: Equal-Weight
Price Target: $70 → $64
Current: $204.88
Upside: -68.76%
May 23, 2022
Maintains: Overweight
Price Target: $275 → $310
Current: $258.21
Upside: +20.06%
Mar 30, 2022
Maintains: Overweight
Price Target: $495 → $565
Current: $320.80
Upside: +76.12%
Nov 10, 2021
Downgrades: Equal-Weight
Price Target: $150 → $75
Current: $3.42
Upside: +2,092.98%
Aug 12, 2021
Upgrades: Overweight
Price Target: $26 → $19
Current: $4.82
Upside: +294.60%
Aug 3, 2021
Maintains: Underweight
Price Target: $6 → $10
Current: $3.60
Upside: +178.16%
May 28, 2021
Downgrades: Underweight
Price Target: $42 → $34
Current: $28.17
Upside: +20.72%
May 24, 2021
Initiates: Overweight
Price Target: $20
Current: $8.96
Upside: +123.21%
Feb 19, 2021
Reinstates: Overweight
Price Target: $260
Current: $87.44
Upside: +197.36%